The annual ASCO meeting is one of the leading showcases for new science about cancer treatment. STAT will take a deep look at the latest data on how to outsmart tumors of all types and a breakdown of the big issues facing developers of new oncology medicines.
Join us to get up to speed on the news and get ready for the future.
AGENDA
6:00 - 6:30 PM CT - Arrival + Registration
6:30 - 6:35 PM CT - Welcome from STAT
Matthew Herper, senior writer, medicine; editorial director of events, STAT
Brian Alexander, M.D., chief executive officer, Foundation Medicine
6:40 - 7:05 PM CT - A Chat With the FDA’s Top Cancer Regulator
Rick Pazdur has built the FDA’s apparatus for regulating cancer medicines, and overseen a revolution in oncology. Hear his latest thinking on targeted medicines, immunotherapy and other new advances, as well as his thoughts about what is going well in cancer drug development and what is not.
Richard Pazdur, M.D., director, Oncology Center of Excellence; acting director, Office of Oncologic Diseases - CDE Offices and Divisions, FDA
Adam Feuerstein, senior writer, biotech, STAT (moderator)
7:05 - 7:15 PM CT - Outsmarting Cancer With Diagnostics | SPONSOR SESSION
For decades, scientists have been trying to crack the code on how cancer originates, evolves, and dissipates. Hear how high-quality diagnostic tests are going beyond connecting patients to appropriate treatment options, but also helping oncologists confidently monitor how a patient’s unique cancer is evolving.
Brian Alexander, M.D., chief executive officer, Foundation Medicine
Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)
7:15 - 7:35 PM CT - AstraZeneca’s Oncology Rx
Over the past decade, AstraZeneca has built itself from a smaller player in oncology to the repeated star of the ASCO meeting. Hear how the company did it from an executive who has been on the front line - and learn where AZ plans to go next.
Susan Galbraith, Ph.D., executive vice-president, oncology R&D, AstraZeneca
Matthew Herper, senior writer, medicine; editorial director of events, STAT (moderator)
7:35 - 8:00 PM CT - STAT Unplugged
STAT’s reporters will take the stage to share convention hall insights, predictions for the months ahead - and of course will take your audience questions live.
Angus Chen, cancer reporter, STAT
Adam Feuerstein, senior writer, biotech, STAT
Matthew Herper, senior writer, medicine; editorial director of events, STAT
Katherine MacPhail, programmer, editorial events, STAT (moderator)